A Placebo-Controlled Comparison of Lithium and Triiodothyronine Augmentation of Tricyclic Antidepressants in Unipolar Refractory Depression
- 1 May 1993
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 50 (5) , 387-393
- https://doi.org/10.1001/archpsyc.1993.01820170065008
Abstract
From JAMA Psychiatry — A Placebo-Controlled Comparison of Lithium and Triiodothyronine Augmentation of Tricyclic Antidepressants in Unipolar Refractory DepressionKeywords
This publication has 19 references indexed in Scilit:
- Lithium Augmentation in Antidepressant-Resistant Patients a Quantitative AnalysisThe British Journal of Psychiatry, 1991
- A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressantsPsychiatry Research, 1990
- Treatment of Endogenous Depressions Resistant to Tricyclic Antidepressants or Related Drugs by Lithium Addition. Results of a Placebo-Controlled Double-Blind StudyPharmacopsychiatry, 1989
- Failure of T3 to potentiate tricyclic antidepressant responseJournal of Affective Disorders, 1987
- The Benefit of Lithium Carbonate Adjunct in Refractory Depression — Fact or Fiction?The Canadian Journal of Psychiatry, 1986
- Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonrespondersAmerican Journal of Psychiatry, 1982
- Lithium Induces Rapid Relief of Depression in Tricyclic Antidepressant Drug Non-RespondersThe British Journal of Psychiatry, 1981
- Combined Therapy of T3 and Antidepressants in DepressionJournal of International Medical Research, 1979
- Combined Thyroid (Triiodothyronine)-Tricyclic Antidepressant Treatment in Depressive StatesPsychiatry and Clinical Neurosciences, 1974
- Thyroid Hormone and Tricyclic Antidepressants in Resistant DepressionsAmerican Journal of Psychiatry, 1970